Nektar Therapeutics, Inc. (NKTR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO, CA 94158

Nektar Therapeutics develops drug delivery systems meant to improve the performance of a drug molecule or how the drug is delivered (e.g., enabling new dosage form or delivery profile that improves how the therapeutic can treat patients).

Data based on most recent fiscal year report
Market Cap15.646 Billion Shares Outstanding157.47 Million Avg Volume3.133 Million
1-Yr BETA vs S&P TR1.785 Current Ratio5.82 Quick Ratio5.63
View SEC Filings from NKTR instead.
Q3 2019 All Institutions Hedge Funds 1
To trade NKTR now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 275 26 (2.72%)
Aggregate 13F shares on 09/30/2019: 172.651 Million 8.057 Million
Aggregate 13F shares on 06/30/2019: 163.516 Million 8.656 Million
Percent change: 5.59% -6.91%
Funds creating new positions: 28 8
Funds Adding to an existing position: 125 13
Funds closing out their position: 80 14
Funds reducing their position: 80 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NKTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

179.1 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

150 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NORTHCOTT JOHN SVP & CHIEF COMMERCIAL OFFICER

  • Officer
200,000 2019-12-02 2

LABRUCHERIE GIL M

  • Director
47,042 2019-11-20 13

ROBIN HOWARD W PRESIDENT & CEO

  • Officer
  • Director
299,629 2019-11-18 9

THOMSEN JILLIAN B. SVP & CHIEF ACCOUNTING OFFICER

  • Officer
160,441 2019-11-18 6

ZALEVSKY JONATHAN CHIEF R&D OFFICER

  • Officer
291,697 2019-11-18 3

AJER JEFFREY ROBERT

  • Director
22,375 2019-09-30 3

CHESS ROBERT

  • Director
276,973 2019-09-27 2

LINGNAU LUTZ

  • Director
26,700 2019-09-27 3

GREER R SCOTT

  • Director
151,583 2019-09-25 2

WHITFIELD ROY A

  • Director
208,250 2019-09-25 1

EASTHAM KARIN

  • Director
15,000 2019-09-25 1

DOBERSTEIN STEPHEN K SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
107,668 2019-09-05 5

LORIANNE MASUOKA K. CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-21 0

NICHOLSON JOHN SVP & CHIEF OPERATING OFFICER

  • Officer
162,759 2019-08-16 4

CHOWRIRA BHARAT M

  • Director
10,000 2019-07-01 0

HORA MANINDER SVP PHARMA DEV & MFG OPS

  • Officer
94,694 2019-05-16 3

GERGEL IVAN P.

  • Director
0 2019-03-15 0

KUEBLER CHRISTOPHER A

  • Director
15,510 2019-01-02 0

WINGER DENNIS L

  • Director
47,750 2018-08-17 0

HUH HOYOUNG

  • Director
0 2018-06-22 0

KRIVULKA JOSEPH J

  • Director
82,000 2017-09-19 0

BROWN MICHAEL A/CA CEO

  • Officer
  • Director
414,016 2016-06-01 0

WANG SUSAN

  • Director
9,887 2016-01-25 0

PATTON JOHN STUART

  • Director
179,876 2014-08-19 0

MEDVE ROBERT SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2014-02-05 0

GHOSH RINKO CHIEF BUSINESS OFFICER

  • Officer
0 2013-02-06 0

MOREADITH RANDALL W SVP DRUG DEVELOPMENT

  • Officer
0 2009-02-23 0

LERNER IRWIN

  • Director
13,200 2009-01-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

NORTHCOTT JOHN - Officer SVP & CHIEF COMMERCIAL OFFICER

2019-12-02 A 200,000 a 200,000 200,000.00 direct

NORTHCOTT JOHN - Officer SVP & CHIEF COMMERCIAL OFFICER

2019-12-02 A 200,000 a 200,000 200,000.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-11-18 S 8,863 $17.97 d 219,009 219,009.00 direct

THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER

2019-11-18 S 2,713 $17.97 d 160,441 160,441.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-11-18 S 13,556 $17.97 d 299,219 299,629.00 direct

ZALEVSKY JONATHAN - Officer CHIEF R&D OFFICER

2019-11-18 S 3,960 $17.97 d 291,697 291,697.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-11-13 S 25,000 $19.79 d 227,872 227,872.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-11-13 M 25,000 $7.21 a 252,872 227,872.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-11-13 M 25,000 d 0 227,872.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-17 M 33,333 $7.21 a 346,108 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-17 M 33,333 d 0 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-17 S 33,333 $17.68 d 312,775 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-16 M 33,334 d 33,333 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-16 S 33,334 $17.48 d 312,775 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-16 M 33,334 $7.21 a 346,109 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-15 M 33,333 $7.21 a 346,108 313,185.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-10-15 S 25,000 $15.83 d 227,872 227,872.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-15 S 24,500 $17.17 d 312,775 313,185.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-10-15 M 25,000 $7.21 a 252,872 227,872.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-15 M 33,333 d 66,667 313,185.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2019-10-15 S 8,833 $16.35 d 337,275 313,185.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2019-10-15 M 25,000 d 25,000 227,872.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments